Abstract
Five leukemic children with toxicity caused by methotrexate had clinical features including severe bone pain during periods of complete hematologic remission and roentgenographic evidence of marked osteoporosis and microfractures. Symptoms responded promptly to cessation of methotrexate therapy, although abnormal x-ray findings persisted for much longer periods. Methotrexate should be suspected as a cause of bone pain in leukemic children maintained with this drug.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
